 | • レポートコード：QYR2104Z5025 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、網膜色素変性症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他）、用途別市場規模（病院、診療所、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・網膜色素変性症治療の市場動向 ・企業の競争状況、市場シェア ・網膜色素変性症治療の種類別市場規模（BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他） ・網膜色素変性症治療の用途別市場規模（病院、診療所、在宅医療） ・網膜色素変性症治療の北米市場規模2016-2027（アメリカ、カナダ） ・網膜色素変性症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・網膜色素変性症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・網膜色素変性症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・網膜色素変性症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astellas Pharma Inc.、Caladrius Biosciences, Inc.、Dompe Farmaceutici S.p.A.、Genable Technologies Limited、Genethon、GenSight Biologics S.A.、Grupo Ferrer Internacional, S.A.、ID Pharma Co., Ltd.、InFlectis BioScience、International Stem Cell Corporation、Ionis Pharmaceuticals, Inc.、M's Science Corporation、Mimetogen Pharmaceuticals Inc.、Nanovector s.r.l.、Orphagen Pharmaceuticals, Inc.） ・結論 |
Market Analysis and Insights: Global Retinitis Pigmentosa Treatment Market
The global Retinitis Pigmentosa Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinitis Pigmentosa Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinitis Pigmentosa Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinitis Pigmentosa Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinitis Pigmentosa Treatment market.
Global Retinitis Pigmentosa Treatment Scope and Market Size
Retinitis Pigmentosa Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinitis Pigmentosa Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
BNP-RP
Cenegermin
CPK-850
Cutamesine
FAB-111
Others
Segment by Application
Hospital
Clinic
Homecare
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Astellas Pharma Inc.
Caladrius Biosciences, Inc.
Dompe Farmaceutici S.p.A.
Genable Technologies Limited
Genethon
GenSight Biologics S.A.
Grupo Ferrer Internacional, S.A.
ID Pharma Co., Ltd.
InFlectis BioScience
Genable Technologies Limited
Genethon
M’s Science Corporation
Mimetogen Pharmaceuticals Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinitis Pigmentosa Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 BNP-RP
1.2.3 Cenegermin
1.2.4 CPK-850
1.2.5 Cutamesine
1.2.6 FAB-111
1.2.7 Others
1.3 Market by Application
1.3.1 Global Retinitis Pigmentosa Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Homecare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinitis Pigmentosa Treatment Market Perspective (2016-2027)
2.2 Retinitis Pigmentosa Treatment Growth Trends by Regions
2.2.1 Retinitis Pigmentosa Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinitis Pigmentosa Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Retinitis Pigmentosa Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Retinitis Pigmentosa Treatment Industry Dynamic
2.3.1 Retinitis Pigmentosa Treatment Market Trends
2.3.2 Retinitis Pigmentosa Treatment Market Drivers
2.3.3 Retinitis Pigmentosa Treatment Market Challenges
2.3.4 Retinitis Pigmentosa Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinitis Pigmentosa Treatment Players by Revenue
3.1.1 Global Top Retinitis Pigmentosa Treatment Players by Revenue (2016-2021)
3.1.2 Global Retinitis Pigmentosa Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Retinitis Pigmentosa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinitis Pigmentosa Treatment Revenue
3.4 Global Retinitis Pigmentosa Treatment Market Concentration Ratio
3.4.1 Global Retinitis Pigmentosa Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa Treatment Revenue in 2020
3.5 Retinitis Pigmentosa Treatment Key Players Head office and Area Served
3.6 Key Players Retinitis Pigmentosa Treatment Product Solution and Service
3.7 Date of Enter into Retinitis Pigmentosa Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinitis Pigmentosa Treatment Breakdown Data by Type
4.1 Global Retinitis Pigmentosa Treatment Historic Market Size by Type (2016-2021)
4.2 Global Retinitis Pigmentosa Treatment Forecasted Market Size by Type (2022-2027)
5 Retinitis Pigmentosa Treatment Breakdown Data by Application
5.1 Global Retinitis Pigmentosa Treatment Historic Market Size by Application (2016-2021)
5.2 Global Retinitis Pigmentosa Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Retinitis Pigmentosa Treatment Market Size (2016-2027)
6.2 North America Retinitis Pigmentosa Treatment Market Size by Type
6.2.1 North America Retinitis Pigmentosa Treatment Market Size by Type (2016-2021)
6.2.2 North America Retinitis Pigmentosa Treatment Market Size by Type (2022-2027)
6.2.3 North America Retinitis Pigmentosa Treatment Market Size by Type (2016-2027)
6.3 North America Retinitis Pigmentosa Treatment Market Size by Application
6.3.1 North America Retinitis Pigmentosa Treatment Market Size by Application (2016-2021)
6.3.2 North America Retinitis Pigmentosa Treatment Market Size by Application (2022-2027)
6.3.3 North America Retinitis Pigmentosa Treatment Market Size by Application (2016-2027)
6.4 North America Retinitis Pigmentosa Treatment Market Size by Country
6.4.1 North America Retinitis Pigmentosa Treatment Market Size by Country (2016-2021)
6.4.2 North America Retinitis Pigmentosa Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Retinitis Pigmentosa Treatment Market Size (2016-2027)
7.2 Europe Retinitis Pigmentosa Treatment Market Size by Type
7.2.1 Europe Retinitis Pigmentosa Treatment Market Size by Type (2016-2021)
7.2.2 Europe Retinitis Pigmentosa Treatment Market Size by Type (2022-2027)
7.2.3 Europe Retinitis Pigmentosa Treatment Market Size by Type (2016-2027)
7.3 Europe Retinitis Pigmentosa Treatment Market Size by Application
7.3.1 Europe Retinitis Pigmentosa Treatment Market Size by Application (2016-2021)
7.3.2 Europe Retinitis Pigmentosa Treatment Market Size by Application (2022-2027)
7.3.3 Europe Retinitis Pigmentosa Treatment Market Size by Application (2016-2027)
7.4 Europe Retinitis Pigmentosa Treatment Market Size by Country
7.4.1 Europe Retinitis Pigmentosa Treatment Market Size by Country (2016-2021)
7.4.2 Europe Retinitis Pigmentosa Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Retinitis Pigmentosa Treatment Market Size (2016-2027)
8.2 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Type
8.2.1 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Application
8.3.1 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region
8.4.1 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinitis Pigmentosa Treatment Market Size (2016-2027)
9.2 Latin America Retinitis Pigmentosa Treatment Market Size by Type
9.2.1 Latin America Retinitis Pigmentosa Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Retinitis Pigmentosa Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Retinitis Pigmentosa Treatment Market Size by Type (2016-2027)
9.3 Latin America Retinitis Pigmentosa Treatment Market Size by Application
9.3.1 Latin America Retinitis Pigmentosa Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Retinitis Pigmentosa Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Retinitis Pigmentosa Treatment Market Size by Application (2016-2027)
9.4 Latin America Retinitis Pigmentosa Treatment Market Size by Country
9.4.1 Latin America Retinitis Pigmentosa Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Retinitis Pigmentosa Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinitis Pigmentosa Treatment Market Size (2016-2027)
10.2 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Type
10.2.1 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Application
10.3.1 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country
10.4.1 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Details
11.1.2 Astellas Pharma Inc. Business Overview
11.1.3 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Introduction
11.1.4 Astellas Pharma Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.1.5 Astellas Pharma Inc. Recent Development
11.2 Caladrius Biosciences, Inc.
11.2.1 Caladrius Biosciences, Inc. Company Details
11.2.2 Caladrius Biosciences, Inc. Business Overview
11.2.3 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Introduction
11.2.4 Caladrius Biosciences, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.2.5 Caladrius Biosciences, Inc. Recent Development
11.3 Dompe Farmaceutici S.p.A.
11.3.1 Dompe Farmaceutici S.p.A. Company Details
11.3.2 Dompe Farmaceutici S.p.A. Business Overview
11.3.3 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Introduction
11.3.4 Dompe Farmaceutici S.p.A. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.3.5 Dompe Farmaceutici S.p.A. Recent Development
11.4 Genable Technologies Limited
11.4.1 Genable Technologies Limited Company Details
11.4.2 Genable Technologies Limited Business Overview
11.4.3 Genable Technologies Limited Retinitis Pigmentosa Treatment Introduction
11.4.4 Genable Technologies Limited Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.4.5 Genable Technologies Limited Recent Development
11.5 Genethon
11.5.1 Genethon Company Details
11.5.2 Genethon Business Overview
11.5.3 Genethon Retinitis Pigmentosa Treatment Introduction
11.5.4 Genethon Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.5.5 Genethon Recent Development
11.6 GenSight Biologics S.A.
11.6.1 GenSight Biologics S.A. Company Details
11.6.2 GenSight Biologics S.A. Business Overview
11.6.3 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Introduction
11.6.4 GenSight Biologics S.A. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.6.5 GenSight Biologics S.A. Recent Development
11.7 Grupo Ferrer Internacional, S.A.
11.7.1 Grupo Ferrer Internacional, S.A. Company Details
11.7.2 Grupo Ferrer Internacional, S.A. Business Overview
11.7.3 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Introduction
11.7.4 Grupo Ferrer Internacional, S.A. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.7.5 Grupo Ferrer Internacional, S.A. Recent Development
11.8 ID Pharma Co., Ltd.
11.8.1 ID Pharma Co., Ltd. Company Details
11.8.2 ID Pharma Co., Ltd. Business Overview
11.8.3 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Introduction
11.8.4 ID Pharma Co., Ltd. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.8.5 ID Pharma Co., Ltd. Recent Development
11.9 InFlectis BioScience
11.9.1 InFlectis BioScience Company Details
11.9.2 InFlectis BioScience Business Overview
11.9.3 InFlectis BioScience Retinitis Pigmentosa Treatment Introduction
11.9.4 InFlectis BioScience Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.9.5 InFlectis BioScience Recent Development
11.10 International Stem Cell Corporation
11.10.1 International Stem Cell Corporation Company Details
11.10.2 International Stem Cell Corporation Business Overview
11.10.3 International Stem Cell Corporation Retinitis Pigmentosa Treatment Introduction
11.10.4 International Stem Cell Corporation Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.10.5 International Stem Cell Corporation Recent Development
11.11 Ionis Pharmaceuticals, Inc.
11.11.1 Ionis Pharmaceuticals, Inc. Company Details
11.11.2 Ionis Pharmaceuticals, Inc. Business Overview
11.11.3 Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Introduction
11.11.4 Ionis Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.11.5 Ionis Pharmaceuticals, Inc. Recent Development
11.12 M’s Science Corporation
11.12.1 M’s Science Corporation Company Details
11.12.2 M’s Science Corporation Business Overview
11.12.3 M’s Science Corporation Retinitis Pigmentosa Treatment Introduction
11.12.4 M’s Science Corporation Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.12.5 M’s Science Corporation Recent Development
11.13 Mimetogen Pharmaceuticals Inc.
11.13.1 Mimetogen Pharmaceuticals Inc. Company Details
11.13.2 Mimetogen Pharmaceuticals Inc. Business Overview
11.13.3 Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Introduction
11.13.4 Mimetogen Pharmaceuticals Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.13.5 Mimetogen Pharmaceuticals Inc. Recent Development
11.14 Nanovector s.r.l.
11.14.1 Nanovector s.r.l. Company Details
11.14.2 Nanovector s.r.l. Business Overview
11.14.3 Nanovector s.r.l. Retinitis Pigmentosa Treatment Introduction
11.14.4 Nanovector s.r.l. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.14.5 Nanovector s.r.l. Recent Development
11.15 Orphagen Pharmaceuticals, Inc.
11.15.1 Orphagen Pharmaceuticals, Inc. Company Details
11.15.2 Orphagen Pharmaceuticals, Inc. Business Overview
11.15.3 Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Introduction
11.15.4 Orphagen Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021)
11.15.5 Orphagen Pharmaceuticals, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Retinitis Pigmentosa Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of BNP-RP
Table 3. Key Players of Cenegermin
Table 4. Key Players of CPK-850
Table 5. Key Players of Cutamesine
Table 6. Key Players of FAB-111
Table 7. Key Players of Others
Table 8. Global Retinitis Pigmentosa Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Retinitis Pigmentosa Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Retinitis Pigmentosa Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Retinitis Pigmentosa Treatment Market Share by Regions (2016-2021)
Table 12. Global Retinitis Pigmentosa Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Retinitis Pigmentosa Treatment Market Share by Regions (2022-2027)
Table 14. Retinitis Pigmentosa Treatment Market Trends
Table 15. Retinitis Pigmentosa Treatment Market Drivers
Table 16. Retinitis Pigmentosa Treatment Market Challenges
Table 17. Retinitis Pigmentosa Treatment Market Restraints
Table 18. Global Retinitis Pigmentosa Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Retinitis Pigmentosa Treatment Market Share by Players (2016-2021)
Table 20. Global Top Retinitis Pigmentosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinitis Pigmentosa Treatment as of 2020)
Table 21. Ranking of Global Top Retinitis Pigmentosa Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Retinitis Pigmentosa Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Retinitis Pigmentosa Treatment Product Solution and Service
Table 25. Date of Enter into Retinitis Pigmentosa Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Retinitis Pigmentosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Retinitis Pigmentosa Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Retinitis Pigmentosa Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Retinitis Pigmentosa Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Retinitis Pigmentosa Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Retinitis Pigmentosa Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Retinitis Pigmentosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Retinitis Pigmentosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Retinitis Pigmentosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Retinitis Pigmentosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Retinitis Pigmentosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Retinitis Pigmentosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Retinitis Pigmentosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Retinitis Pigmentosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Retinitis Pigmentosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Retinitis Pigmentosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Retinitis Pigmentosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Retinitis Pigmentosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Retinitis Pigmentosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Retinitis Pigmentosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Retinitis Pigmentosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Retinitis Pigmentosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Retinitis Pigmentosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Retinitis Pigmentosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Astellas Pharma Inc. Company Details
Table 66. Astellas Pharma Inc. Business Overview
Table 67. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Product
Table 68. Astellas Pharma Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 69. Astellas Pharma Inc. Recent Development
Table 70. Caladrius Biosciences, Inc. Company Details
Table 71. Caladrius Biosciences, Inc. Business Overview
Table 72. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Product
Table 73. Caladrius Biosciences, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 74. Caladrius Biosciences, Inc. Recent Development
Table 75. Dompe Farmaceutici S.p.A. Company Details
Table 76. Dompe Farmaceutici S.p.A. Business Overview
Table 77. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Product
Table 78. Dompe Farmaceutici S.p.A. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 79. Dompe Farmaceutici S.p.A. Recent Development
Table 80. Genable Technologies Limited Company Details
Table 81. Genable Technologies Limited Business Overview
Table 82. Genable Technologies Limited Retinitis Pigmentosa Treatment Product
Table 83. Genable Technologies Limited Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 84. Genable Technologies Limited Recent Development
Table 85. Genethon Company Details
Table 86. Genethon Business Overview
Table 87. Genethon Retinitis Pigmentosa Treatment Product
Table 88. Genethon Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 89. Genethon Recent Development
Table 90. GenSight Biologics S.A. Company Details
Table 91. GenSight Biologics S.A. Business Overview
Table 92. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Product
Table 93. GenSight Biologics S.A. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 94. GenSight Biologics S.A. Recent Development
Table 95. Grupo Ferrer Internacional, S.A. Company Details
Table 96. Grupo Ferrer Internacional, S.A. Business Overview
Table 97. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Product
Table 98. Grupo Ferrer Internacional, S.A. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 99. Grupo Ferrer Internacional, S.A. Recent Development
Table 100. ID Pharma Co., Ltd. Company Details
Table 101. ID Pharma Co., Ltd. Business Overview
Table 102. ID Pharma Co., Ltd. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 103. ID Pharma Co., Ltd. Recent Development
Table 104. InFlectis BioScience Company Details
Table 105. InFlectis BioScience Business Overview
Table 106. InFlectis BioScience Retinitis Pigmentosa Treatment Product
Table 107. InFlectis BioScience Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 108. InFlectis BioScience Recent Development
Table 109. International Stem Cell Corporation Company Details
Table 110. International Stem Cell Corporation Business Overview
Table 111. International Stem Cell Corporation Retinitis Pigmentosa Treatment Product
Table 112. International Stem Cell Corporation Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 113. International Stem Cell Corporation Recent Development
Table 114. Ionis Pharmaceuticals, Inc. Company Details
Table 115. Ionis Pharmaceuticals, Inc. Business Overview
Table 116. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product
Table 117. Ionis Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 118. Ionis Pharmaceuticals, Inc. Recent Development
Table 119. M's Science Corporation Company Details
Table 120. M's Science Corporation Business Overview
Table 121. M's Science Corporation Retinitis Pigmentosa Treatment Product
Table 122. M's Science Corporation Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 123. M's Science Corporation Recent Development
Table 124. Mimetogen Pharmaceuticals Inc. Company Details
Table 125. Mimetogen Pharmaceuticals Inc. Business Overview
Table 126. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Product
Table 127. Mimetogen Pharmaceuticals Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 128. Mimetogen Pharmaceuticals Inc. Recent Development
Table 129. Nanovector s.r.l. Company Details
Table 130. Nanovector s.r.l. Business Overview
Table 131. Nanovector s.r.l. Retinitis Pigmentosa Treatment Product
Table 132. Nanovector s.r.l. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 133. Nanovector s.r.l. Recent Development
Table 134. Orphagen Pharmaceuticals, Inc. Company Details
Table 135. Orphagen Pharmaceuticals, Inc. Business Overview
Table 136. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product
Table 137. Orphagen Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2016-2021) & (US$ Million)
Table 138. Orphagen Pharmaceuticals, Inc. Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinitis Pigmentosa Treatment Market Share by Type: 2020 VS 2027
Figure 2. BNP-RP Features
Figure 3. Cenegermin Features
Figure 4. CPK-850 Features
Figure 5. Cutamesine Features
Figure 6. FAB-111 Features
Figure 7. Others Features
Figure 8. Global Retinitis Pigmentosa Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Homecare Case Studies
Figure 12. Retinitis Pigmentosa Treatment Report Years Considered
Figure 13. Global Retinitis Pigmentosa Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Retinitis Pigmentosa Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Retinitis Pigmentosa Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Retinitis Pigmentosa Treatment Market Share by Regions (2022-2027)
Figure 17. Global Retinitis Pigmentosa Treatment Market Share by Players in 2020
Figure 18. Global Top Retinitis Pigmentosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinitis Pigmentosa Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa Treatment Revenue in 2020
Figure 20. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Retinitis Pigmentosa Treatment Market Share by Type (2016-2027)
Figure 24. North America Retinitis Pigmentosa Treatment Market Share by Application (2016-2027)
Figure 25. North America Retinitis Pigmentosa Treatment Market Share by Country (2016-2027)
Figure 26. United States Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Retinitis Pigmentosa Treatment Market Share by Type (2016-2027)
Figure 30. Europe Retinitis Pigmentosa Treatment Market Share by Application (2016-2027)
Figure 31. Europe Retinitis Pigmentosa Treatment Market Share by Country (2016-2027)
Figure 32. Germany Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Retinitis Pigmentosa Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Retinitis Pigmentosa Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Retinitis Pigmentosa Treatment Market Share by Region (2016-2027)
Figure 42. China Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Retinitis Pigmentosa Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Retinitis Pigmentosa Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Retinitis Pigmentosa Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Retinitis Pigmentosa Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Retinitis Pigmentosa Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Retinitis Pigmentosa Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Retinitis Pigmentosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Astellas Pharma Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 62. Caladrius Biosciences, Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 63. Dompe Farmaceutici S.p.A. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 64. Genable Technologies Limited Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 65. Genethon Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 66. GenSight Biologics S.A. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 67. Grupo Ferrer Internacional, S.A. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 68. ID Pharma Co., Ltd. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 69. InFlectis BioScience Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 70. International Stem Cell Corporation Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 71. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 72. M's Science Corporation Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 73. Mimetogen Pharmaceuticals Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 74. Nanovector s.r.l. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 75. Orphagen Pharmaceuticals, Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の網膜色素変性症治療＆管理市場規模・現状・予測（2021年-2027年） Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision. Retinitis pigmentosa is generally inherited from a person's parents. Mutations in one of more than 50 genes is involved. Market Analysis and Insights: Global Retinitis Pigmentosa Treatment & Management Market The…- 世界のサイトメガロウイルス（CMV）網膜炎治療市場規模・現状・予測（2021年-2027年） Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related …
- 世界の網膜芽細胞腫治療市場規模・現状・予測（2021年-2027年） Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. Market Analysis and Insights: Global Retinoblastoma Treatment Market The global Retinoblastoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during…
- 世界の光線療法治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Phototherapy Treatment Market The global Phototherapy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年） Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in seri…